CCC - Clarivate Plc


Weak GrowthEarnings/Profit is Negative


based on last 5 year data.
Income Statement is WEAK
Revenue Growth is 9.94%
Operating Income is Negative
Net Income is Negative
Earnings Per Share (EPS) is Negative but improving
Net Margin is -18.62%
Balance Sheet is WEAK
Current Asset to Current Liability Ratio is 1.42
Debt Ratio is 0.54
Current Debt to Net Income Ratio not available
Total Debt to Total Assets Ratio is 0.38
Cash Flow is WEAK
Cash from Operations Growth is 18.34%
Capital Expenditure not available
Net Increase in Cash is Positive
Long Term Score Trend is NEGATIVE
Investment Risk is High
based on last 4 quarter data.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Clarivate Plc (CCC) -
Clarivate Plc provides trusted insights and analytics to accelerate the pace of innovation. Its solutions include scientific and research, patent intelligence and compliance standards, pharmaceutical and biotech intelligence and trademark, domain and brand protection. The company product portfolio includes Life Science, Web of Science, Cortellis, Derwent, CompuMark, MarkMonitor and Techstreet. It helps clients to reduce the time from new ideas to life changing innovations. The company was founded in 1864 and is headquartered in London.
Exchange - New York Stock Exchange
Industry - Miscellaneous Commercial Services
Sector - Commercial Services
CEO - Jerre Lee Stead
Employees - 4,203

Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.